Regenerative Medicine
Platelet-Rich Plasma Injections Show Promise for Tennis Elbow Pain Relief
New trial tests whether PRP injections can reduce tennis elbow pain better than standard treatments in 72 participants.
Clinical Trial
Mar 28, 2026 0
Results for "Therapeutic Plasma Exchange"
20 articles
Brain Health
Repurposed Anti-Nausea Drug TEP Tested for Clearing Alzheimer's Brain Plaques
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Clinical Trial
Jun 12, 2026 0
Autoimmune & Arthritis
Carfilzomib Combination Therapy Takes Aim at Lung Transplant Rejection
A Phase II pilot trial tests whether adding carfilzomib to plasma exchange and IVIG can safely reverse antibody-mediated rejection after lung transplantation.
Clinical Trial
Jun 26, 2026 0
Regenerative Medicine
Platelet-Rich Plasma Shows Promise for Chronic Ear Inflammation Treatment
Small trial tests blood-derived therapy for persistent post-surgical ear infections that resist standard treatments.
Clinical Trial
Mar 29, 2026 1
Autoimmune & Arthritis
Placental Stem Cell Secretome Tested as GvHD Treatment in Phase 3 Trial
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
Clinical Trial
May 12, 2026 0
Brain Health
Phase 3 Trial Zeros In on Optimal EPO Dose and Timing for Traumatic Optic Nerve Injury
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
Clinical Trial
Jun 9, 2026 0
Regenerative Medicine
PRP Injections Show Promise for Shoulder Arthritis Pain Relief
Clinical trial tests platelet-rich plasma therapy for shoulder osteoarthritis in 91 patients over 5 months.
Clinical Trial
Mar 28, 2026 0
Regenerative Medicine
Platelet-Rich Plasma Shows Promise for Knee Osteoarthritis Pain Relief
150-person trial tests whether PRP injections can reduce knee pain and improve function better than placebo in osteoarthritis patients.
Clinical Trial
Mar 28, 2026 0
Cancer Research
T-VEC Plus Pembrolizumab Tested in Melanoma After Anti-PD-1 Failure
Phase 2 trial explores whether combining oncolytic virus therapy with immunotherapy can rescue patients whose melanoma progressed on PD-1 blockade.
Clinical Trial
May 29, 2026 0
Cancer Research
CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial
Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.
Clinical Trial
Mar 28, 2026 1
Heart Health
Phase 3 Trial Tests Tafamidis for TTR Amyloid Heart Disease
Pfizer's landmark trial examines whether tafamidis can safely treat transthyretin amyloid cardiomyopathy, a progressive and often fatal heart condition.
Clinical Trial
Jun 13, 2026 0
Autoimmune & Arthritis
Early Rheumatoid Arthritis Treatment Shows Promise for Rapid Remission
Small study tests whether tocilizumab can achieve faster, deeper remission in newly diagnosed rheumatoid arthritis patients.
Clinical Trial
Mar 28, 2026 3
Cancer Research
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Clinical Trial
Mar 28, 2026 0
Autoimmune & Arthritis
UK Trial of Biologics for Refractory Rare Vasculitis Terminated Early
A Phase 2 trial testing rituximab, infliximab, and tocilizumab for hard-to-treat non-ANCA vasculitis was terminated before completion.
Clinical Trial
May 20, 2026 0
Autoimmune & Arthritis
Phase 3 Trial Tests Infliximab as a Powerful Treatment for Plaque Psoriasis
A completed Phase 3 trial evaluated whether the anti-TNF biologic infliximab safely and effectively treats plaque psoriasis.
Clinical Trial
Jun 2, 2026 0
Cancer Research
Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Clinical Trial
Mar 29, 2026 12
Autoimmune & Arthritis
PI vs NNRTI Regimens Face Off in Severely Immunocompromised HIV Patients
A Phase 4 trial compares two antiretroviral strategies in treatment-naive HIV patients with dangerously low CD4 counts below 100.
Clinical Trial
Jun 18, 2026 0
Cancer Research
Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer
Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.
Clinical Trial
Mar 28, 2026 1
Regenerative Medicine
PRP and Ozone Injections Show Promise for Knee Arthritis Pain Relief
New study compares two regenerative therapies for knee osteoarthritis, offering alternatives to steroid injections.
Clinical Trial
Mar 28, 2026 0
Brain Health
New Blood Test Could Predict Stroke Recovery Success Using Tiny Cellular Messengers
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.
Clinical Trial
Mar 28, 2026 0
Page 1 of 2Next